Module 2: Clinical Manifestations and Laboratory Studies
This learning activity has been designated for 1.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in this activity.
After completing this educational activity, the learner should be better able to:
- Explain the history of chronic myelogenous leukemia (CML) and the discovery of BCR-ABL as the central defect related to disease pathogenesis
- Review the available diagnostics and their use in the diagnosis and management of CML
- Describe the typical and unusual presentations of CML
- Manage specific complications of CML
This learning activity is intended for medical oncologists, hematologists, stem cell transplant physicians, and other interested healthcare professionals who manage and treat chronic myelogenous leukemia in the hematology/oncology and transplant patient settings.
Release Date: November 30, 2008
Expiration date: November 30, 2009
(*Please check this box to proceed - required)
Start the Module